Zug, Zug, Switzerland
Stanislas Guy has been General Manager Switzerland at Vertex since April 2022. Strategic and result-oriented business leader with 15 years of international experience in pharmaceutical & biotech industry. Well-rounded executive leader with broad experience in innovative therapies (incl. gene therapies) commercialization in rare diseases, market access and with strong financial background. Recognized for cross-functional leadership, building trust-based relationships and influencing diverse stakeholders to advance business priorities. Critical thinker and forward looking, adept of designing business strategies and driving seamless execution. Passionate about building an engaging and diverse culture, experienced in developing high-performing teams.
Lead Switzerland affiliate, develop country strategy and supervise all operations, successfully launch new therapies, shape external environment to ensure business growth and local access to therapies. Lead, expand and develop country cross-functional teams while fostering a collaborative and inclusive culture. Lead country cross-functional organization, develop high performing teams and enhance a positive and collaborative culture. • Lead country cross-functional organization, develop high performing teams and enhance a positive and collaborative culture • Adapt Corporate strategy to Swiss market to drive revenue growth (> +60% since 2021) and optimize P&L via resource re-allocation • Define commercialization strategy for new assets (Small molecules & 1st CRISPR-Cas9 Gene Therapy in various rare diseases including cystic fibrosis, rare blood disorders), supervise execution of cross-functional plans including marketing campaigns and commercial messaging • Lead the design of reimbursement and pricing strategy for all Vertex products in Switzerland and directly negotiate with public/private payers • Shape external environment and communicate externally, strengthening relationships with key external stakeholders (HCPs, policy makers, patient groups, media) to advance business priorities • Role model company values and ethical behaviour while ensuring full compliance with external & internal legal standards and policies
Member of the International Leadership Team, shape strategy and drive execution of the goals partnering with all cross-functional leaders. Support SVP with oversight for the organization and growth of the business running key international operations, including integrated planning and performance management. Lead various strategic and complex projects driving value and improving efficiency. • Supported development of the international strategy, define goals and ensure appropriate implementation via integrated planning and performance management (commercial KPIs reviews) • Managed International LT and various Leadership forums to ensure cross-functional integration, supporting and challenging diverse Sr Leaders to foster a continuous improvement mindset • Optimized International governance and ways of working • Led or supported various strategic projects: o New gene therapy commercialization strategy & operating (G2M) model o Roll-out of new Brand Planning process to bring greater strategic thinking & better align with other key planning exercises o Roadmap to upgrade targeted capabilities: Analytics, Market Access, Cell & Gene Therapies across the organization o In partnership with HR, program aiming at improving specific leadership behaviours (continuous learning, enterprise thinking, feedback & coaching culture)
Led International Finance Operations and strategic & finance planning, providing advice to CFO and LT to support strategic decision making. Actively support analytics and forecasting to generate insights to ensure business growth and appropriate resource allocation. • Managed International financial statements, driving revenue growth (sales tripled in 3 years), increased profitability by more than 10% and improved forecast accuracy (>95% in 2020) • Owned forecasting process and improved planning leading to better analytics and insights • Market Access: key partner to develop International & country pricing policy, support to multiple markets on local access strategy & pricing modelling leading to access unlocked in >10 markets • Commercial & financial assessment of new pipeline products • Led assessment of expansion into various geographies & part of distributor selection process (set-up of new partner in Russia) • Set-up of new framework / process to better assess and manage cross-boarder trade, resulting in reduced revenue loss • Led and developed a successful team of 10 people – 100% team members have been promoted within or outside of Finance
Established and led new Financial Planning & Analysis (FP&A) Center of Excellence for Europe Middle East and Africa Region (>60 countries, $8B revenue) • Drove key financial operations and improved all key financial KPIs • Led overall finance function optimisation enabling continuous improvement in all FP&A activities • Led the integration of Actelion company into Janssen for EMEA: assessment of synergies & development of new organizational model design, cultural integration, process/system integration • Recruited, built, and develop a diverse 35-people team to support the whole EMEA region
Rotational programme (1 year in France, 1 year in Germany) and frequent trainings / assignments in the USA.